4th Quarter - Report

AMERICAN SOCIETY FOR CLINICAL PATHOLOGY for AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

Firm
Client
Income
—
Expenses
$43,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.

LobbyistCovered position, as disclosed
MATTHEW SCHULZE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform

LobbyistCovered position, as disclosed
MATTHEW SCHULZE —

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Labor Issues/Antitrust/Workplace LBR

Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.

LobbyistCovered position, as disclosed
MATTHEW SCHULZE —

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Education, Dept of; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform

LobbyistCovered position, as disclosed
MATTHEW SCHULZE —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Bureau of Labor Statistics (BLS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.